Psychotropic Drugs: Risks and Risk Management

Abstracts (HTML) List of Authors

Haen, E

Measurement of the concentrations of active agents in drugs using UHPLC (Ultra High Pressure Liquid Chromatography) – and HPLC and UV-detection
Beta-blockers in psychiatry: Pharmacokinetic interactions of antipsychotics with CYP2D6- HPLC as a quantitative method for analysis in TDM
Age-dependency of the risk for tricyclic antidepressant-associated anticholinergic adverse reactions
Quantification of thirteen psychotherapeutic agents and their metabolites using column switching HPLC/UV
Enzyme assay to study the metabolism of quetiapine and the influence of psychotropic comedication on the concentration of quetiapine
Age- and sex-dependency of psychotropic drug induced hyperprolactinemia
The frequency and cost comparison of haloperidol prescriptions – haloperidol data analysis from therapeutic drug monitoring 2006–2011

Haen, W

Depressive disorders in childhood and adolescence 2010– a KinderAGATE analysis

Hahn, M

Increasing drug therapy safety in psychiatry: implementing a pharmacist on the ward

Hansen, D

Therapeutic drug monitoring (TDM) in children and adolescents treated with aripiprazole

Harenberg, S

Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression

Haueis, P

Comparative performance of two drug interaction screening programs analyzing a cross-sectional prescription dataset of 84,625 psychiatric inpatients

Hefner, G

Evaluation of a risk-scale for anticholinergic side-effects in elderly psychiatric inpatients

Henkel, K

Plasma levels and cerebrospinal fluid penetration of venlafaxine in a patient with a non-fatal overdose during a suicide attempt

Hiemke, C

Evaluation of a risk-scale for anticholinergic side-effects in elderly psychiatric inpatients
Therapeutic drug monitoring (TDM) in plasma and amniotic fluid in pregnancy
Cost-effectiveness potential of therapeutic drug monitoring for depressed inpatients treated with citalopram by shortening of hospitalization
Citation of the AGNP consensus guidelines for therapeutic drug monitoring in psychiatry 2004 in the scientific literature 2004 to 2011
Therapeutic drug monitoring (TDM) and clinical outcomes in forensic patients under clozapine therapy compared to therapies with other antipsychotic drugs
Therapeutic drug monitoring of bupropion for depression

Hilleret, H

Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression

Himmerich, H

Agomelatine in breast milk

Huemer, J

Therapeutic drug monitoring of olanzapine in children and adolescents with anorexia nervosa: A pilot study